After a career-long tenure at Bayer, Nelson Ambrogio has climbed the ranks to the top of the pharma heap as newly appointed president of the German conglomerate’s U.S. pharmaceuticals division. The executive will officially take over on May 1, leaving his current post as president of Bayer’s global radiology business to join the company’s worldwide markets leadership team in his new role.


